Form D · Other

Reactive Biosciences Inc.

Durham, NC · CIK 0001700096

Offering snapshot reported Jun 22, 2023 · SEC filing

Reported sold
$4M
Offering amount: $4M
Investors reported
10
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Jun 12, 2023
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Jun 22, 2023Initial$4,000,000No comparison10SEC filing
Sep 12, 2022Initial$23,499,998No comparison10SEC filing
May 15, 2020Amendment$2,000,000$0vs Jan 3, 202014SEC filing
Jan 3, 2020Initial$2,000,000No comparison14SEC filing
Feb 28, 2019Initial$3,000,000No comparison14SEC filing
Mar 22, 2017Initial$10,530,292No comparison28SEC filing

Offering details

Securities
Debt
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-484853

Source: Form D, filed Jun 22, 2023. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Stephen Benkovic Director
Kristina Burow Executive
John Dombrosky Executive
Peter Farina Director
Rich Gianni Executive
Julie Grant Director, Executive
Tracy Jackson Executive
Raj Kaul Director
Roger Kemble Director, Executive
Joel Marcus Director
Paul Schimmel Director
Esther Van Den Boom Executive

Issuer details

Industry: Other (See others in industry)

Address:
8 Davis Drive, Suite 320
Durham, NC, 27709